NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (Nasdaq:PSTI)(DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, announces that William R. Prather RPh, MD, Sr. VP Corporate Development, will present at the Fourth Annual Noble Financial Equity Conference at 12:30 p.m. (Pacific) on Tuesday, August 19, 2008 at the Loews Lake Las Vegas Resort, Nevada.
